Leukocyte telomere length and plasma interleukin-1β and interleukin-18 levels in mild cognitive impairment and Alzheimer’s disease: new biomarkers for diagnosis and disease progression?

Disease Progression ◽

Telomere Length ◽

Interleukin 1Β ◽

Leukocyte Telomere Length ◽

Interleukin 18 ◽

New Biomarkers

Association of Leukocyte Telomere Length with Mild Cognitive Impairment and Alzheimer’s Disease: Role of Folate and Homocysteine

Dementia and Geriatric Cognitive Disorders ◽

10.1159/000501958 ◽

2019 ◽

Vol 48 (1-2) ◽

pp. 56-67 ◽

Cited By ~ 2

Author(s):

Fei Ma ◽

Xin Lv ◽

Yue Du ◽

Hui Chen ◽

Shuai Liu ◽

...

Keyword(s):

Alzheimer’S Disease ◽

Alzheimer's Disease ◽

Cognitive Impairment ◽

Telomere Length ◽

Leukocyte telomere length in mild cognitive impairment and Alzheimer's disease patients

Experimental Gerontology ◽

10.1016/j.exger.2017.08.025 ◽

2017 ◽

Vol 98 ◽

pp. 143-147 ◽

Cited By ~ 19

Author(s):

Daniela Scarabino ◽

Elisabetta Broggio ◽

Giuseppe Gambina ◽

Rosa Maria Corbo

Keyword(s):

Alzheimer’S Disease ◽

Alzheimer's Disease ◽

Cognitive Impairment ◽

Telomere Length ◽

Leukocyte Telomere Length (LTL) is reduced in stable mild cognitive impairment but low LTL is not associated with conversion to Alzheimer's Disease: A pilot study

Experimental Gerontology ◽

10.1016/j.exger.2011.12.005 ◽

2012 ◽

Vol 47 (2) ◽

pp. 179-182 ◽

Cited By ~ 31

Author(s):

Sofia Movérare-Skrtic ◽

Per Johansson ◽

Niklas Mattsson ◽

Oskar Hansson ◽

Anders Wallin ◽

...

Keyword(s):

Alzheimer’S Disease ◽

Alzheimer's Disease ◽

Cognitive Impairment ◽

Pilot Study ◽

Telomere Length ◽

Relationship between proinflammatory cytokines (Il-1beta, Il-18) and leukocyte telomere length in mild cognitive impairment and Alzheimer's disease

Experimental Gerontology ◽

10.1016/j.exger.2020.110945 ◽

2020 ◽

Vol 136 ◽

pp. 110945 ◽

Cited By ~ 3

Author(s):

D. Scarabino ◽

M. Peconi ◽

E. Broggio ◽

G. Gambina ◽

E. Maggi ◽

...

Keyword(s):

Alzheimer’S Disease ◽

Alzheimer's Disease ◽

Cognitive Impairment ◽

Telomere Length ◽

Proinflammatory Cytokines ◽

P4-640: DISEASE PROGRESSION AND COSTS AT 1-YEAR FOLLOW-UP OF GERAS-US: A 3-YEAR STUDY OF MILD COGNITIVE IMPAIRMENT AND MILD DEMENTIA DUE TO ALZHEIMER'S DISEASE IN THE UNITED STATES

Alzheimer s & Dementia ◽

10.1016/j.jalz.2019.09.006 ◽

2019 ◽

Vol 15 ◽

pp. P1574-P1574

Author(s):

Julie Chandler ◽

Anthony Zagar ◽

Yongin Kim ◽

Brandy R. Matthews ◽

Rebecca L. Robinson ◽

...

Keyword(s):

United States ◽

Alzheimer’S Disease ◽

Alzheimer's Disease ◽

Cognitive Impairment ◽

Disease Progression ◽

The United States ◽

Mild Dementia

Plasma Aβ42 as a Biomarker of Prodromal Alzheimer’s Disease Progression in Patients with Amnestic Mild Cognitive Impairment: Evidence from the PharmaCog/E-ADNI Study

Journal of Alzheimer s Disease ◽

10.3233/jad-180321 ◽

2019 ◽

Vol 69 (1) ◽

pp. 37-48 ◽

Cited By ~ 12

Author(s):

Diego Albani ◽

Moira Marizzoni ◽

Clarissa Ferrari ◽

Federica Fusco ◽

Lucia Boeri ◽

...

Keyword(s):

Alzheimer’S Disease ◽

Alzheimer's Disease ◽

Cognitive Impairment ◽

Disease Progression ◽

Amnestic Mild Cognitive Impairment ◽

Prodromal Alzheimer’S Disease

Combinatorial Markers of Mild Cognitive Impairment Conversion to Alzheimer's Disease - Cytokines and MRI Measures Together Predict Disease Progression

Journal of Alzheimer s Disease ◽

10.3233/jad-2011-0044 ◽

2011 ◽

Vol 26 (s3) ◽

pp. 395-405 ◽

Cited By ~ 32

Author(s):

Simon J. Furney ◽

Deborah Kronenberg ◽

Andrew Simmons ◽

Andreas Güntert ◽

Richard J. Dobson ◽

...

Keyword(s):

Alzheimer’S Disease ◽

Alzheimer's Disease ◽

Cognitive Impairment ◽

Disease Progression ◽

Predict Disease Progression

Disease progression model in subjects with mild cognitive impairment from the Alzheimer's disease neuroimaging initiative: CSF biomarkers predict population subtypes

British Journal of Clinical Pharmacology ◽

10.1111/j.1365-2125.2012.04308.x ◽

2012 ◽

Vol 75 (1) ◽

pp. 146-161 ◽

Cited By ~ 31

Author(s):

Mahesh N. Samtani ◽

Nandini Raghavan ◽

Yingqi Shi ◽

Gerald Novak ◽

Michael Farnum ◽

...

Keyword(s):

Alzheimer’S Disease ◽

Alzheimer's Disease ◽

Cognitive Impairment ◽

Disease Progression ◽

Csf Biomarkers ◽

Progression Model ◽

Disease Progression Model

65. Cortical sources of resting state EEG rhythms reflect disease progression over 1year in mild cognitive impairment and Alzheimer’s disease patients

Clinical Neurophysiology ◽

10.1016/j.clinph.2013.06.092 ◽

2013 ◽

Vol 124 (11) ◽

pp. e203-e204

Author(s):

R. Lizio ◽

C. Babiloni ◽

C. Del Percio ◽

N. Marzano ◽

A. Soricelli ◽

...

Keyword(s):

Alzheimer’S Disease ◽

Alzheimer's Disease ◽

Cognitive Impairment ◽

Disease Progression ◽

Resting State ◽

Eeg Rhythms ◽

Cortical Sources

O1-05-06: Apathy and depression in Alzheimer's disease and mild cognitive impairment: Occurrence and association with disease progression

Alzheimer s & Dementia ◽

10.1016/j.jalz.2010.05.238 ◽

2010 ◽

Vol 6 ◽

pp. S80-S80

Author(s):

Katie Palmer ◽

Fulvia Di Iulio ◽

Carlo Caltagirone ◽

Gianfranco Spalletta

Keyword(s):

Alzheimer’S Disease ◽

Alzheimer's Disease ◽

Cognitive Impairment ◽

Disease Progression